{{Rsnum
|rsid=13252298
|Chromosome=8
|position=127082911
|Orientation=plus
|GMAF=0.2599
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=PRNCR1
|Gene_s=PRNCR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 35.4 | 12.4
| HCB | 40.9 | 44.5 | 14.6
| JPT | 51.3 | 41.6 | 7.1
| YRI | 98.0 | 2.0 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 40.9 | 44.5 | 14.6
| CHD | 36.7 | 51.4 | 11.9
| GIH | 22.8 | 55.4 | 21.8
| LWK | 92.7 | 7.3 | 0.0
| MEX | 39.7 | 48.3 | 12.1
| MKK | 71.8 | 27.6 | 0.6
| TSI | 50.0 | 44.1 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=A
|Pval=0.000004
|OR=1.1200
|ORtxt=[1.05-1.18]
|OA=1
}}

{{PMID Auto
|PMID=24779299
|Title=Study of genetic variants of 8q21 and 8q24 associated with prostate cancer in Jing-Jin residents in northern China
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}